1966
DOI: 10.1002/jps.2600550307
|View full text |Cite
|
Sign up to set email alerts
|

Analogs of Tetrahydrofolic Acid XXXII

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

1967
1967
2002
2002

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(4 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…The preparation of this compound was achieved by the reaction of N-Boc-protected GSH 7 (20) with the mono-Boc-protected MDI derivative 6. The Bocprotected MDI derivative 6 was prepared starting with the literature known amino acid 4 (21). Reaction with excess Boc 2 O under standard conditions resulted in good yields of compound 5, which was converted in a straightforward manner to the isocyanate 6 under Curtius conditions (22).…”
Section: Resultsmentioning
confidence: 99%
“…The preparation of this compound was achieved by the reaction of N-Boc-protected GSH 7 (20) with the mono-Boc-protected MDI derivative 6. The Bocprotected MDI derivative 6 was prepared starting with the literature known amino acid 4 (21). Reaction with excess Boc 2 O under standard conditions resulted in good yields of compound 5, which was converted in a straightforward manner to the isocyanate 6 under Curtius conditions (22).…”
Section: Resultsmentioning
confidence: 99%
“…A large number of studies of the specificity of the dihydrofolate binding site (particularly for inhibitors) have been reported (see Blakley, 1969;Baker, 1967). The majority of these studies have been concerned with the pteridine moiety of the substrate or inhibitor, though the binding of NHjBzGlu has been recognized for a number of years (Baker et al, 1966). While it is true that the major part of the very considerable binding energy of methotrexate and related compounds (IF0 = -12 to -15 kcal/mol) is attributable to the pteridine ring, significant variations in affinity are seen with changes in the NHiBzGlu moiety (Baker et al, 1964;Blakley, 1969;Johns et al, 1973).…”
Section: Discussionmentioning
confidence: 99%
“…The irreversible inhibition of phosphorylase b was a very specific reaction (Table III). Sulfonyl fluoride derivatives were chosen as irreversible inhibitors because a specific reversible complex of the moiety bearing the SG2F group with the enzyme must be formed before the SG2F group will react and form a covalent linkage (Baker et al, 1966). Two sulfonyl fluoride derivatives, XXXVI and XXXVIII, significantly irreversibly modify phosphorylase b, but showed no activity in the absence of AMP.…”
Section: Discussionmentioning
confidence: 99%